FindTrial
Sign In

To compare the effect of magnesium sulphate and/or fentanyl added to intrathecal bupivacaine on Blood Pressure, Heart Rate and post operative Pain in elective caserean section.

To compare the effect of magnesium sulphate and/or fentanyl added to intrathecal bupivacaine on haemodynamics and post operative analgesia in parturients undergoing elective cesarean section.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/05/006931
Enrollment
90
Registered
2016-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA 1and 2 Parturient undergoing Elective LSCS

Interventions

Control Intervention1: fentanyl and Magnesium Sulfate with Bupivacaine: To compare the synergistic effects of magnesium sulphate and/or fentanyl with bupivacaine 0.5% (H) on hemodynamics , quality and

Sponsors

Dr RPGMC Kangra at Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.parturients undergoing elective cesarean section 2.ASA class 1-2 3.BMI <40

Exclusion criteria

Exclusion criteria: 1. Patientâ??s refusal for consent. 2. Patients having bleeding disorders, thrombocytopenia 3. Local infection at the site where needle for block is to be inserted. 4. Allergic to study drugs. 5. Pregnancy induced hypertension, HELLP syndrome 6. Anemia 7. Patients in whom the block effect will be partial and will require supplementary anesthesia. 8. Parturient is on magnesium therapy 9. Fetal distress

Design outcomes

Secondary

MeasureTime frame
hemodynamic stability beginning of sensory and motor block time to maximal sensory block duration of sensory motor block use of vasopressor and demand of rescue analgesiaTimepoint: from 0 to 24 hrs post operatively—

Primary

MeasureTime frame
time of 1st resuce AnalgesiaTimepoint: time of 1st resuce Analgesia—

Countries

India

Contacts

Public ContactDr Shelly Rana

Dr. RPGMC Kangra at Tanda

dryuvraj18@gmail.com7831977366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026